Scalable Market Access Strategies Targeting Payers in the US

Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Many DTx vendors in the US have targeted payers as their market access model, however, the lack of standardization of reimbursement pathways makes scalable strategies difficult for DTx companies in the US. Currently, demands change across payer organizations, thus DTx vendors tend to approach them on a case-by-case basis, making scaling difficult. Identifying the optimal market access strategies to target and scale within the US payer system is challenging, both in terms of engaging the different types of payers (e.g. Medicaid/Medicare, commercial payers, etc.) and negotiating contract terms to ensure long-term success beyond pilots or small-scale projects. 

How can DTx vendors in the US establish scalable market access strategies to gain reimbursement across different payers and geographies? Join this meeting for senior leaders in DTx to deep dive into the following: